Evidence map›Paper›PMID 36256911›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/

Andishe Attarbaschi, Anja Möricke, Christine J Harrison, Georg Mann, André Baruchel, Barbara De Moerloose, Valentino Conter, Meenakshi Devidas, Sarah Elitzur, Gabriele Escherich and 13 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. TARGET based mBMC pediatrics · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 19 institutions in 12 countries.

Andishe AttarbaschiSt Anna Children's Hospital and St Anna Children's Cancer Research Institute, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-9285-6898
Anja MörickeChristian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
Christine J HarrisonLeukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle upon Tyne, United Kingdom.
Georg MannSt Anna Children's Hospital and St Anna Children's Cancer Research Institute, Medical University of Vienna, Vienna, Austria.
André BaruchelRobert Debré University Hospital (APHP), Université Paris Cité, Paris, France.ORCID 0000-0003-0120-6089
Barbara De MoerlooseGhent University Hospital, Ghent, Belgium.ORCID 0000-0002-2449-539X
Valentino ConterUniversity of Milano-Bicocca, MBBM Foundation/ASST Monza, Monza, Italy.ORCID 0000-0001-5697-4929
Meenakshi DevidasDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN.
Sarah ElitzurSchneider Children's Medical Center, Tel Aviv, Israel.ORCID 0000-0002-3495-7578
Gabriele EscherichClinic of Paediatric Haematology and Oncology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Stephen P HungerChildren's Hospital of Philadelphia, Philadelphia, PA.ORCID 0000-0002-5492-3957
Keizo HoribeNational Hospital Organization Nagoya Medical Center, Nagoya, Japan.ORCID 0000-0002-6251-6059
Atsushi ManabeHokkaido University Graduate School of Medicine, Sapporo, Japan.
Mignon L LohBen Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA.ORCID 0000-0003-4099-4700
Rob PietersPrincess Máxima Centre for Pediatric Oncology, Utrecht, the Netherlands.ORCID 0000-0003-2997-3570
Kjeld SchmiegelowRigshospitalet and University Hospital Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-0829-4993
Lewis B SilvermanBoston Children's Hospital and Harvard Medical School, Boston, MA.
Jan StaryUniversity Hospital Motol and Charles University, Prague, Czech Republic.ORCID 0000-0002-6818-7743
Ajay VoraGreat Ormond Street Hospital, London, United Kingdom.ORCID 0000-0002-2167-4368
Ching-Hon PuiSt Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0003-0303-5658
Martin SchrappeChristian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.ORCID 0000-0003-0034-5845
Martin ZimmermannMedical School Hannover, Hannover, Germany.
Ponte-di-Legno Childhood Acute Lymphoblastic Leukemia Working Group
Christian-Albrechts-Universität zu Kiel · DESt Anna Children's Hospital · ATSt. Jude Children's Research Hospital · USBoston Children's Hospital · USCharles University · CZChildren's Hospital of Philadelphia · USGhent University Hospital · BEGreat Ormond Street Hospital · GBHokkaido University · JPMedizinische Hochschule Hannover · DENational Hospital Organization · JPNewcastle University · GBPrincess Máxima Center · NLSeattle Children's Hospital · USTel Aviv University · ILUniversität Hamburg · DEUniversité Paris Cité · FRUniversity of Copenhagen · DKUniversity of Milano-Bicocca · IT

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG FOREIGN ACCRUALU10CA098543 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI ADAMSON, PETER C. · 2003 to 2013
$335.5M
Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Children's Oncology Group Statistics &Data Center GrantU10CA098413 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI DEVIDAS, MEENAKSHI · 2003 to 2013
$67.5M
NCI NIH HHS P30 CA021765NCI NIH HHS U10 CA098413NCI NIH HHS U10 CA098543NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899
6 · The paper itself

Abstract

purposeWe aimed to study prognostic factors and efficacy of allogeneic hematopoietic stem-cell transplantation (allo-HSCT) in first remission of patients with noninfant childhood acute lymphoblastic leukemia (ALL) with 11q23/ PATIENTS AND

methodsData were retrospectively retrieved from 629 patients with 11q23/

resultsA specific 11q23/

conclusionCompared with historical data, prognosis of patients with noninfant 11q23/

Indexed as

Biological ProductsHematopoietic Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaChromosomes, Human, Pair 11Histone-Lysine N-MethyltransferaseHumansMyeloid-Lymphoid Leukemia ProteinNeoplasm, ResidualPrognosisRecurrenceRetrospective StudiesTranslocation, GeneticBiological ProductsHistone-Lysine N-MethyltransferaseKMT2A protein, humanMyeloid-Lymphoid Leukemia Protein

Identifiers

PMID36256911
PMCPMC9995095
OpenAlexW4306724812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.